aTyr Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.17
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
1
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.47
|
-0.31
|
0.16
|
34.04%
|
|
2022-09-30
|
-0.46
|
-0.46
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.38
|
-0.44
|
-0.06
|
-15.79%
|
|
2022-03-31
|
-0.33
|
-0.44
|
-0.11
|
-33.33%
|
|
2021-12-31
|
-0.28
|
-0.31
|
-0.03
|
-10.71%
|
|
2021-09-30
|
-0.60
|
-0.42
|
0.18
|
30.00%
|
|
2021-06-30
|
-0.51
|
-0.64
|
-0.13
|
-25.49%
|
|
2021-03-31
|
-0.32
|
-0.51
|
-0.19
|
-59.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.65
|
|
2021-12-31
|
-1.88
|
|
2020-12-31
|
-1.59
|
|
2019-12-31
|
-7.33
|
|
2018-12-31
|
-16.24
|
|
2017-12-31
|
-19.18
|
|
2016-12-31
|
-2.44
|
|
2015-12-31
|
-11.31
|
|
2013-12-31
|
1.02
|